Israeli startup NeuroCare’s new blood test lets doctors predict exactly how patients’ brains will respond to antidepressants—potentially ending the trial-and-error approach to mental health treatment.
The post WATCH: Israeli tech could end guesswork in prescriptions appeared first on World Israel News.